Health Condition 1: G440- Cluster headaches and other trigeminal autonomic cephalgias (TAC)
Conditions
Interventions
Intervention1: CARBAMAZEPINE PLUS PERIPHERAL NERVE BLOCK: 2 percent Lignocaine peripheral nerve block will be given in involved branch once a week for four weeks along with 100 mg Carbamazepine BD whi
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Classical and Idiopathic Neuralgia Newly diagnosed Trigeminal Neuralgia patients or with remission of 1 months or more Patient consent for participation in this study
Exclusion criteria
Exclusion criteria: Secondary Trigeminal Neuralgia patients Patients on anti psychotics History of excessive alcohol intake Hepatic or renal insufficiency Known tolerance or allergy to study drug Pregnancy or Lactation Non compliant during screening period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Numeric Pain Rating Scale (NPRS) assessment of painTimepoint: 0 1 2 3 weeks 1 month 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To evaluate mean dose of carbamazepine used in both the groups 2 To evaluate number of responders with 50 percent relief in pain. 3 LIKERTs scale for assessment of quality of life 4 LIKERTs scale for Patient Satisfaction 5 Adverse effects as reported by the patientTimepoint: 0 1 2 3 weeks 1 month 3 months | — |
Countries
India
Contacts
Public ContactDr Jyoti Bhatt
Outcome results
None listed